Helen Ross-Stubblefield v. Laura L. Weakland

CourtCourt of Appeals of Georgia
DecidedJune 2, 2021
DocketA21A0053
StatusPublished

This text of Helen Ross-Stubblefield v. Laura L. Weakland (Helen Ross-Stubblefield v. Laura L. Weakland) is published on Counsel Stack Legal Research, covering Court of Appeals of Georgia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Helen Ross-Stubblefield v. Laura L. Weakland, (Ga. Ct. App. 2021).

Opinion

FIRST DIVISION BARNES, P. J., GOBEIL and MARKLE, JJ.

NOTICE: Motions for reconsideration must be physically received in our clerk’s office within ten days of the date of decision to be deemed timely filed. https://www.gaappeals.us/rules

DEADLINES ARE NO LONGER TOLLED IN THIS COURT. ALL FILINGS MUST BE SUBMITTED WITHIN THE TIMES SET BY OUR COURT RULES.

May 20, 2021

In the Court of Appeals of Georgia A21A0053. ROSS-STUBBLEFIELD et al. v. WEAKLAND et al.

MARKLE, Judge.

Helen Ross-Stubblefield and her husband (collectively “the plaintiffs”) brought

a medical malpractice suit against Helen’s oncologist, Laura Weakland, and

Weakland’s medical practice, Georgia Cancer Specialists (collectively “the

defendants”), alleging that Weakland failed to follow up on abnormal test results, and

that this failure led to a delay in the diagnosis and treatment of Helen’s cancer. A jury

found in favor of the defendants, and the plaintiffs now appeal, arguing that the trial

court erred in admitting medical records of a non-party treating physician because

those records were altered after the litigation began, were made with an intent to conceal relevant facts, in violation of OCGA § 16-10-94.1, and were not properly

certified.1 Because we conclude that any error was harmless, we affirm.

Viewing the evidence in the light most favorable to the verdict, Turrell v.

McNeel, 333 Ga. App. 611, 612 (774 SE2d 274) (2015), the record shows that in

2012, Helen was diagnosed with stage III breast cancer. Dr. Rogsbert Phillips

performed a mastectomy, and Helen underwent chemotherapy with Dr. Weakland,

and radiation with another doctor. Helen responded well to the treatment and, once

it was completed, the plaintiffs began to discuss reconstructive surgery. In September

2013, per Dr. Phillips’s orders, Helen obtained a PET scan and an MRI in preparation

for reconstructive surgery. The PET scan report showed a nodule behind the sternum,

and the radiologist recommended additional imaging. The plaintiffs met with Dr.

Phillips and discussed the results of the scans, but apparently were not told that the

scan was abnormal.

1 The plaintiffs also named a physician assistant as a defendant, but the trial court granted a directed verdict as to the claims against her. In addition, the plaintiffs initially alleged simple negligence, fraud, and breach of fiduciary duty. The trial court granted summary judgment in Dr. Weakland’s favor on the simple negligence and breach of fiduciary duty claims, but denied it as to the fraud claim. The plaintiffs do not allege any error with respect to these rulings.

2 At Helen’s next appointment the following month, Dr. Weakland had reviewed

the reports and indicated that there was no evidence of disease. She also noted in the

record that she would follow up on the PET and MRI results. Thereafter, Dr.

Weakland assumed that Dr. Phillips had reviewed the scans, and that the MRI results

clarified that there was nothing concerning about the results of the PET scan.

Unfortunately, Helen’s cancer had returned and was not discovered until

Dr. Phillips ordered another set of scans in early 2015. At that time, Helen was

diagnosed with stage IV cancer that is incurable.

The plaintiffs’ claims of negligence and fraud stem from Dr. Weakland’s

failure to look into the results of the 2013 PET scan and her subsequent notations in

Helen’s medical record that there was no evidence of disease at that time. At trial, the

plaintiffs sought to exclude Dr. Phillips’s medical records, which included an entry

from 2015 and an altered version of that same note.2 In the original, Dr. Phillips wrote

that Helen was “still thinking about reconstruction. Wants a complete staging prior

to surgery.” After the litigation began, Dr. Phillips changed that entry to read: “Still

2 The plaintiffs also filed suit against Dr. Phillips in a separate action, and they unsuccessfully challenged the admissibility of these altered records in that suit as well. In a deposition given in that case, Dr. Phillips admitted changing the note, explaining that she had “amended” her earlier entry. Dr. Phillips did not testify in Dr. Weakland’s trial.

3 thinking about reconstruction suregry [sic]. She has not been consistent in keeping

her appointment. The office has been trying to get patient in fot [sic] a follow up CT-

Pet scan. Denies any symptoms. Last time seen in office was almost 8 months ago.”

The plaintiffs moved in limine to exclude these records on the grounds that they had

been altered after litigation began and were not made contemporaneously with the

examination; they were not properly certified; and they violated OCGA § 16-10-94.1,

which criminalizes the falsification of medical records.3 In response, Dr. Weakland

submitted a certification of the records. The trial court denied the motion to exclude

the records. The plaintiffs then referred to the altered note in opening statements,

asserting that Dr. Weakland would likely try to blame Helen for the delay in

treatment, consistent with Dr. Phillips’s altered note.

The plaintiffs presented expert testimony from an oncologist who opined that

Dr. Weakland breached the standard of care by failing to follow up with the 2013

PET scan results and for noting in Helen’s chart that there was no evidence of disease

when the PET scan was, in fact, abnormal. This expert witness also criticized Dr.

Phillips’s decision to alter the record, and explained that the note regarding Helen’s

3 In opposing the motion in limine, the defendants asserted that they could remove those two altered lines. But they also argued that the entire record was admissible.

4 noncompliance was inconsistent with the rest of the medical records. The plaintiffs

also presented testimony from a surgical oncologist, who testified that it was

improper for Dr. Weakland to note in the record that there was no evidence of disease

in light of the abnormal PET scan results. He opined that the delay in treatment due

to the failure to follow up on the abnormal scan caused Helen to need extensive

surgery and reduced her life expectancy.

Both Helen and her husband testified that Helen had been diligent in her

treatment, that Dr. Weakland never told them the results of the 2013 PET scan, and

that she should have told them of the result so that they could have pursued further

treatment.

Dr. Weakland testified that she had reviewed the PET scan report, but that she

assumed that the doctor who ordered the test had investigated the abnormal results,

and that the MRI had confirmed that there was no reason for concern. She stated that

Helen was well-educated about her condition and treatment, and that Helen informed

her that the scans were clear. Dr. Weakland explained that she wrote no evidence of

disease in the chart because, after reviewing the report, she did not think the PET scan

showed an active cancer, as it was not unusual for a scan to show some abnormality

after a patient had completed surgery and radiation. Dr. Weakland further explained

5 that there was only a very small chance of recurrence so soon after treatment based

on her experience treating cancer patients, as well as Helen’s lab work, and the

physical examination.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Ferro v. Boswell
530 S.E.2d 533 (Court of Appeals of Georgia, 2000)
Pembrook Management, Inc. v. Cossaboon
278 S.E.2d 100 (Court of Appeals of Georgia, 1981)
Snider v. Basilio
637 S.E.2d 40 (Supreme Court of Georgia, 2006)
Goldsmith v. Peterson
703 S.E.2d 694 (Court of Appeals of Georgia, 2010)
TURRELL Et Al. v. McNEEL Et Al.
774 S.E.2d 274 (Court of Appeals of Georgia, 2015)
Chua v. Johnson
784 S.E.2d 449 (Court of Appeals of Georgia, 2016)
Fritz Swint v. Tonya Mae
798 S.E.2d 23 (Court of Appeals of Georgia, 2017)
MOORE v. WELLSTAR HEALTH SYSTEM, INC. Et Al.
824 S.E.2d 787 (Court of Appeals of Georgia, 2019)
Griffin v. Greene County Hospital Authority
578 S.E.2d 913 (Court of Appeals of Georgia, 2003)
Thomas v. Emory Clinic, Inc.
739 S.E.2d 138 (Court of Appeals of Georgia, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
Helen Ross-Stubblefield v. Laura L. Weakland, Counsel Stack Legal Research, https://law.counselstack.com/opinion/helen-ross-stubblefield-v-laura-l-weakland-gactapp-2021.